IL2 and neoplasm: When IL-2 is present, stimulation by phosphoantigens results in the selective and swift expansion of Vδ2 T cells ex vivo, which exhibit anti-tumor activity in vitro, as is observed in cases of multiple myeloma and renal cell carcinoma [1, 33–36].